These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34277651)

  • 41. Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury.
    Donato MT; Tolosa L
    Differentiation; 2019; 106():15-22. PubMed ID: 30844688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Derivation and applications of human hepatocyte-like cells.
    Li S; Huang SQ; Zhao YX; Ding YJ; Ma DJ; Ding QR
    World J Stem Cells; 2019 Aug; 11(8):535-547. PubMed ID: 31523372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential applications of induced pluripotent stem cells (iPSCs) in hepatology research.
    Sun C; Wilson GS; Fan JG; Qiao L
    Curr Stem Cell Res Ther; 2015; 10(3):208-15. PubMed ID: 25599714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioprinting of human pluripotent stem cells and their directed differentiation into hepatocyte-like cells for the generation of mini-livers in 3D.
    Faulkner-Jones A; Fyfe C; Cornelissen DJ; Gardner J; King J; Courtney A; Shu W
    Biofabrication; 2015 Oct; 7(4):044102. PubMed ID: 26486521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Live-cell screening platform using human-induced pluripotent stem cells expressing fluorescence-tagged cytochrome P450 1A1.
    Kim JW; Im I; Kim H; Jeon JS; Kang EH; Jo S; Chun HS; Yoon S; Kim JH; Kim SK; Park HJ
    FASEB J; 2020 Jul; 34(7):9141-9155. PubMed ID: 32421247
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Zakikhan K; Pournasr B; Vosough M; Nassiri-Asl M
    Cell J; 2017; 19(2):204-217. PubMed ID: 28670513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application.
    Ito E; Miyagawa S; Takeda M; Kawamura A; Harada A; Iseoka H; Yajima S; Sougawa N; Mochizuki-Oda N; Yasuda S; Sato Y; Sawa Y
    Sci Rep; 2019 Feb; 9(1):1881. PubMed ID: 30760836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pharmaceutical Research on Liver Diseases Using iPS Cell and Genome Editing Technologies].
    Takayama K
    Yakugaku Zasshi; 2019; 139(10):1219-1225. PubMed ID: 31582604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical potential of human-induced pluripotent stem cells : Perspectives of induced pluripotent stem cells.
    Kumar D; Anand T; Kues WA
    Cell Biol Toxicol; 2017 Apr; 33(2):99-112. PubMed ID: 27900567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation of hepatobiliary organoids from human induced pluripotent stem cells.
    Wu F; Wu D; Ren Y; Huang Y; Feng B; Zhao N; Zhang T; Chen X; Chen S; Xu A
    J Hepatol; 2019 Jun; 70(6):1145-1158. PubMed ID: 30630011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of Human Pluripotent Stem Cell-Derived Hepatic Cell Phenotype by Three-Dimensional Hydrogel Models.
    Toivonen S; Malinen MM; Küblbeck J; Petsalo A; Urtti A; Honkakoski P; Otonkoski T
    Tissue Eng Part A; 2016 Jul; 22(13-14):971-84. PubMed ID: 27329070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of the mechanism underlying liver diseases using human induced pluripotent stem cells.
    Kakinuma S; Watanabe M
    Immunol Med; 2019 Jun; 42(2):71-78. PubMed ID: 31498713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in Human Induced Pluripotent Stem Cell-Derived Hepatocytes for Use in Toxicity Testing.
    Wills LR; Rajagopalan P
    Ann Biomed Eng; 2020 Mar; 48(3):1045-1057. PubMed ID: 31372857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional coculture of sympathetic neurons and cardiomyocytes derived from human-induced pluripotent stem cells.
    Winbo A; Ramanan S; Eugster E; Jovinge S; Skinner JR; Montgomery JM
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H927-H937. PubMed ID: 32822546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of Induced Pluripotent Stem Cells in Liver Diseases.
    Yu Y; Wang X; Nyberg SL
    Cell Med; 2014 Nov; 7(1):1-13. PubMed ID: 26858888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Highly sensitive droplet digital PCR method for detection of residual undifferentiated cells in cardiomyocytes derived from human pluripotent stem cells.
    Kuroda T; Yasuda S; Matsuyama S; Tano K; Kusakawa S; Sawa Y; Kawamata S; Sato Y
    Regen Ther; 2015 Dec; 2():17-23. PubMed ID: 31245455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Perspectives regarding the potential use of human induced pluripotent stem cells for the development of and research on medicinal products].
    Hayakawa T; Mizuguchi H
    Brain Nerve; 2012 Jan; 64(1):47-57. PubMed ID: 22223501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reprogramming of bone marrow derived mesenchymal stromal cells to human induced pluripotent stem cells from pediatric patients with hematological diseases using a commercial mRNA kit.
    Sfougataki I; Grafakos I; Varela I; Mitrakos A; Karagiannidou A; Tzannoudaki M; Poulou M; Mertzanian A; Roubelakis G M; Stefanaki K; Traeger-Synodinos J; Kanavakis E; Kitra V; Tzetis M; Goussetis E
    Blood Cells Mol Dis; 2019 May; 76():32-39. PubMed ID: 30709626
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells.
    Simara P; Tesarova L; Rehakova D; Farkas S; Salingova B; Kutalkova K; Vavreckova E; Matula P; Matula P; Veverkova L; Koutna I
    Stem Cells Dev; 2018 Jan; 27(1):10-22. PubMed ID: 29117787
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Could co-transplantation of iPS cells derived hepatocytes and MSCs cure end-stage liver disease?
    Liu T; Wang Y; Tai G; Zhang S
    Cell Biol Int; 2009 Nov; 33(11):1180-3. PubMed ID: 19716896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.